Hitting a daily high of $.0034 on news that January revenues were up more than 420% over the same month during 2006, NatureWell Inc. (OTCBB: NAWL) seems to be making the move from a nice idea to a distributor of significant units.

Commenting on today's news, CEO James Arabia stated: "These sales numbers reflect the efforts of our multi-pronged marketing strategy, of which we are in the earliest stages," "It is exciting to see our long-awaited strategy begin to bear fruit. The results are very encouraging and I am optimistic about what we can achieve as our marketing efforts expand and mature. We are constantly evaluating sales techniques and ways to educate healthcare professionals about MigraSpray in order to convince them of the benefits of making MigraSpray available to their patients, and we are only in the beginning of that process."

Since the company is coming to market with what it claims to be the only known over-the-counter migraine treatment that may be used for acute treatment and prevenuetion of migraines, it's a safe been that sales will continue to trend upwards in the near term.

With US market for migraine “treatment” remedies estimated at $1.5 billion and the “untapped” migraine prevention market in US at nearly $3.5 billion annually, NAWL, in our opinion is extremely well positioned to gain significant traction within the migraine market

Labels: Break Out, Migraine, Migraine Headache, Naturewell, Naturewell Inc., NAWL